t*cuSign ID D￿D39CF4lts￿1e￿￿e74o￿l9Al52626
Intemational Agency for the Prevention of Blindness.. cons01￿ated Report and Finan￿81 Ststement5 for the Year Ended 31 De(Ember 2023
INTERNATIONAL AGENCY FOR THE PREVENTION OF BLINDNESS
TRUSTEES, REPORT AND CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED
31 DECEMBER 2023
Company number.. 04620869
Page 1 of 35

t*cuSign ID D￿D39CF4lts￿1e￿￿e74o￿l9Al52626
Intemational Agency for the Prevention of Blindness.. cons01￿ated Report and Finan￿81 Ststement5 for the Year Ended 31 De(Ember 2023
CONTENTS
Page
Tru$lee$' Report
IndependentAuditorfs Report to the Members of InternationalAgency for the Prevention of
Blindness
13
Consolidated Statement of Finan￿81 Activities
17
Consolidated and Chanty Balance Sheets
18
Consolidated Cash Flow Statement
19
Notes to the Financial Statements
20
Page 2 of 35


|**NAME**|**POSITION / NOMINATED BY**|**APPOINTED**|**RESIGNED**|
|---|---|---|---|
|**Officers**||||
|Caroline Casey|President|||
|Muhammad Babar Qureshi|Vice President|||
|Debra Davis|Treasurer|||
|**Appointed Trustees (Founding and 'Category A' Members) non-**||||
|**corporate**||||
|Martine Abel-Williamson|World Blind Union|||
|Jess Blijkers|Light for the World|||
|Rainer Brockhaus|CBM|||
|Jennifer Chen|The Chen Yet-Sen Family Foundation|4 February 2024||
|Jennifer Gersbeck|The Fred Hollows Foundation (FHF)|||
|Ella Gudwin|Vision Spring|||
||International Council of|||
|Neeru Gupta|Ophthalmology|||
|Caroline Harper|Sightsavers International|||





|**NAME**|**POSITION / NOMINATED BY**|**APPOINTED**|**RESIGNED**|
|---|---|---|---|
|Scott Mundle|World Council of Optometry||2 April 2024|
|Cindy Tromans|World Council of Optometry|2 April 2024||
|Haidong Zou|Shanghai Eye Disease Centre|||
|**Elected Trustees**||||
|Kashinath Bhoosnurmath|Operation Eyesight|||
|Wei He|He Eye Specialist Hospital|||
|Derek Hodkey|Orbis|||
|Nick Kourgialis|Helen Keller International||30 April 2024|
|Elizabeth Kurian|Mission for Vision|||
|Fatima Kyari|International Centre for Eye Health|||
|Katherine Overbey|Himalayan Cataract Project|||
|Bruce Spivey|Ophthalmology Foundation|25 June 2023||
|**Regional Chairs and Other**||||
|**Trustees**||||
||Regional Chair, Eastern|||
|Abdulaziz Ibrahim AlRajhi|Mediterranean|||
|Marcus Ang|Singapore Eye Research Institute||1 July 2023|
|Francisco Martinez Castro|Regional Chair, Latin America|||
|Amanda Davis|Regional Chair, Western Pacific|||
|Suzanne Gilbert|Regional Chair, North America|||
|Wolfgang Gindorfer|Regional Chair, Europe|||
|Rohit Khanna|Regional Chair, South East Asia|||
|Aaron Magava|Regional Chair, Africa|||






t*cuSign ID D￿D39CF4lts￿1e￿￿e74o￿l9Al52626
Intemational Agency for the Prevention of Blindness.. cons01￿ated Report and Finan￿81 Ststement5 for the Year Ended 31 De(Ember 2023
Je8sica Thornpson
Director of Policy, Strategy and Advocacy
Neil Hedgecock
Finance Director Iconsuttantl toAugust 2023
Judith Wilson
Interim Finan￿ Director Iconsuhantl from Septernber 2023- May
2024
Professlonal advlce and seNlces
HSBC Bank, 16 King Street, London, WC2E 8JF
Convera UK Limited. Alphabeta Building. 14.18 Finsbury Square. London EC2A 1AH.
Crowe U.K. LLP, Black Country House. Rounds green Road. Oldbury. West Midlands. B69 2DG. Auditors.
STRUCTURE, GOVERNANCE AND MANAGEMENT
IAPB is constituted as an intemational membership organisation. The Memorsndum snd Articles ofAssocistion dated Decernber 2002 and
amended in September 2007 and 2023 set out the objects and powers of the organisation. The charity is governed by a Board of Trustees ¥vhi¢h
has lrfal, financial and oversight ￿SPOnSibl1itY for the charity and delegates day to day management and decision-making to the Chief Executive
Offi￿r and senior team.
TheAudit Committee have reviewed The Charity Govemanct Code and applied the appropriate standards of ￿¢0MMended practice.
The trustees constitute direct015 of the chairtable cornpany for the purpose5 of the CompanEsAct 2006 and tIUStees of the chairty foi the purposes
of the Charities A¢t 2011. Trustees are ￿¢r￿rted and appointed in accordan￿ wth the Articles olAsso¢iation as either Officers. Appointed trustees,
Elected trustee5 lelected by IAPB'S membership organisationsl, or Regional chsirs l individuals.
When an elected trustee vacancy arises. all members are notified that an election will tske place and they are invited to stand through an online
nomination proc£ss. All members are then inwted to vote for one csndid8te per 8eat via our electronic platfonr. When voting doses the person wrth
the most votes is elected as a tIU51ee.
All trustees receive an induction which indudes rneetings with the CEO and other rnembers of the executive team All trustees are required to
complete a consent fo￿ and a declaration of interest form. DeclaratlOn5 of interest and related parties a￿ re-confirmed annually.
The Executive Committee approve the arrangements for setting the remuneration of the charrty's key management personnel and wider staff each
year. Every three years a pay benchmaTking review is carried out to ensure that retnuneiation for all staff remains appropriate to their role and
location.
Sub-committ885.' the Board has established two sub-wmTnittees". the Executive Committee, which meets every other month, and theAudit
Committee, which meets iwice a year.
Page 5 of 35

t*cuSign ID D￿D39CF4lts￿1e￿￿e74o￿l9Al52626
Intemational Agency for the Prevention of Blindness.. cons01￿ated Report and Finan￿81 Ststement5 for the Year Ended 31 De(Ember 2023
Subsidiary company.. the charity has a vtholly-owned subsidiary company, IAPB Trading Limited, which has not traded in 2023 or 2022.
STATEMENT OF PUBLIC BENEFIT
IAPB exists for global public benefrt., it lead5 a global allian￿ of organisations seeking excellen￿ and equity in the provision of eye health serVi￿S
with the purpose to reduce the number of people globally that experien¢e visual impaim)ents.
The trustees have considered the Charity Commission's guidan￿ on public benefrt, induding the gUidan￿'PUb1iC benefit." a chatily (P82J'
and a￿ confident that the Charity's intent and its performan￿ cleady demonslrale that IAPB provides a global public benefrt.
OBJECTIVES AND ACTIVITIES
The vision of the organisation is to have a wodd where no one experien￿$ unne￿$sarY or preventable sight loss and everyone Can a¢hieve their
A public heahh challenge as large as sight loss. whith affects over 1.1 billion ol us. requires colle¢tive action by governments. private sedor, Civil
society, professionals and the wider public. Representing a unique and unparalleled global membership from over 100 countries. IAPB is a nDt-for-
profit charity, solely focused on delivering the collective goal to end avoidable sight loss and driving awareness of eye health around the worfd. IAPB
members range from international charities, eye hospitals and academic institutes through to profession81 bodies and Corporates. On behalf of this
diverse and unique mix of 0ry8ni88tions. we provide a powerful, unrfied and trusted voice Dn an issue th8t affects every human on the p18net. We
work tirelessly to ensure our sector gets the political, health and developtnent priority it needs and deserve5. We work through collective action at
the intersection of public health, development and markets. We ensure that our rrembers, vol￿$ are heard at the highest levels and fight to unlock
political wll and fInan￿ng while a150 changing pe￿ptionS and policy.
In addition to our advocacy work, our activities include.. building a global eviden￿ base with practical tools and approaches. designing and
coordinating glob81 awareness r8i5ing campaigns about the importance of eye health. and bringing together and convening eye health organisation5
and others lo develop approaches to Improve a￿$$. develop capacrty and use technology to ￿ath people who do not have a¢￿$$ to the eye
care seNices they need.
2030 In Sight Objectives- ending avoidable sight loss
2030 In Sight is the sector's strategic plan to ensure that eye health receives the global political. health and developmental priority it needs to
enable aC￿sS to eye care forthe rnore than 1.1 billion people who do not currently have ac￿$5 to the setvices they need.
The objectives of 2030 Irj Sight are th8t. by 2D30. we want to see a Wor￿ where..
No-one experiences un￿e￿$Sary or preventable sight loss and everyone can achieve their full potential.
Page 6 of 35

t*cuSign ID D￿D39CF4lts￿1e￿￿e74o￿l9Al52626
Intemational Agency for the Prevention of Blindness.. cons01￿ated Report and Finan￿81 Ststement5 for the Year Ended 31 De(Ember 2023
Eye care and rehabilitation serv1￿5 are &c￿ssible, indusive and affordable to everyone. everywhere, whenever they are needed.
People understand the importano of caring for their own eye heatth and demand actsss to Servi￿$, free from the weight of any social
stigma.
Grdllt.making activiti85, volunte8f5, and social inv8Stment5
The tharity has not made any use of grant-making or volunteers to deliver its activities during 2023.
The charity is aware of the power to make social Investments underthe CharitiesAct 2011 las amended) and will keep this under review.
ACHIEVEMENTS AND PERFORMANCE
The main achievements of the charity have induded hosting a major suc￿$$fUl intemational event, 2030 In Sight Live, in Singapore," advocacy
work at a global level.. and strong campaigns for Love Your Eye$ and World Sight Day. Highlights for 2023 included..
Strong commitments on eye health induded in the UN'S dedaration on Universal Health Coverage.
Partnership arrangement wth the International Labour Organisation and a joint rtport on"Eye Health and the World olwork
An event in the margins of the UN General Assembly where 3 prime ministers and more than 15 health and other ministers c£lled for eye
health to be prioritized.
For the first lime four countries ￿port on eye health in their Voluntsry National Reviews of their progress on iMp￿MentIng the Sustainable
Development Goals.
Half a billion people ￿ached through social media through our Love Your Eyes and Wodd Sight Day campaigns to raise awareness about the
importanc* of eye health.
Over 60 countries and more than 150 eye health organ15ations joined the call for a UN Speaal Envoy on vision.
Our 2030 Insight Live event attracted over 350 delegates from 46 Countries lo listen to 92 speakers of ¥thom more than 50/0 were women.
Aw8rded 'ASSo￿ation of the Ye8r' 8nd'C8mpaign of the Yearf (for Love Your Eyes) by the Assou8tion ofAssou8tion Executives.
New funding agreement with Islamic Development Bank.
IAPB Eye He311h Technology Guide launched to support the scale up of eye care Servi￿$.
Allian￿ signed with 'Pan AMeri￿n Academy of Ophthalmology, to end avoidable sight loss in Latin Afflerica.
30 new member organisations.
Page 7 of 35


|**formance**<br>**year**<br>ught forward<br>**ried forward**|**Unrestricted**<br>**Restricted**<br>**Total**<br>**£**<br>**£**<br>**£**<br>2,090,025<br>988,961<br>3,078,986<br>(2,267,424)<br>(1,152,062)<br>(3,419,486)<br>**(177,399)**<br>**(163,101)**<br>**(340,500)**<br>782,007<br>177,070<br>959,077<br>**604,608**<br>**13,969**<br>**618,577**|
|---|---|






t*cuSign ID D￿D39CF4lts￿1e￿￿e74o￿l9Al52626
Intemational Agency for the Prevention of Blindness.. cons01￿ated Report and Finan￿81 Ststement5 for the Year Ended 31 De(Ember 2023
FINANCIAL MANAGEMENT POLICIES
Investment policy- the charity does not hold Investments and wll keep the option under review.
Reserves policy- The definition of reserves used follows the guidan￿ given by the Charrty Commission. These are funds available to be used in
furtheran￿ of the charitable objects which have not yet been spent. committed or designated. They therefore exclude restricted fund5 Iwhere
donors impose criteria for their usel, fixed a55ets (which ale in current Use to 5UPPOrt the ongoing wotk of the charity) and any funds designated for
specific purposes.
TheAudit Committee ￿vIewS the reserves policy annually to detemine the level of unrestricted ￿ServeS which shoukl be held by the charity.
The Un￿strICted free reserves of £593,679 held at 31 De￿mber 2023 rep￿sent 3.1 months. budgeted unrestricted operating expenditure.
Where unrtstricted free ￿ServeS are above the policy level. the Trustees have the flexibility to apply these lo Invest in furthering the charity's
objects where appropriate over time. The level and fomi of resewes held Is report￿ at ead) Board meeting Compliance with the Reserves Policy
is monitored periodically by the Audit Committee.
STATEMENT OF GOING CONCERN
The Trustees and the senior management team have reviewed thè latest financial position and have considered high level financial projections
through to December 2025. Future performan￿ will be supported by the financial principles th8t unrestricted reserves wll be m8intained in line with
the rese￿e8 policy and restricted funding will be secured before a restricted project b￿1n8 Dr is extended.
Based on finan￿81 perforrnsnce to date for 2024, the foward projections and continued adheren￿ to financial princip￿8, the Trustees consider that
the charrty rtmains a going concern". the accounts have been p￿Pared on this basis.
KEY RISKS AND UNCERTAINTIES
The Trustees are responsible for the management of the risks fatsd by the charity. The Aud([ Committee provides scrutiny of the risk ￿gIster iwee
a year and ￿pOrtS to the Board which also re￿iveS the risk rtgister. The senior management team keep the risk register under ￿VIeW on an
ongoing basis.
Key controls which support Trustees in managing risk indude".
Formal agenda for Board meetings
Detsiled ternis of reference for the B08rd and sub-cornmittees
Cornprehensive 51rategi¢ and business planning, budgeting and management accounting prO￿$Se$
Established organisational slwcture and lines of reporting. and
Formal spprov81 and delegation of the annual budget, including authorisation and approvsl level5.
The principal risk5 and mitigating actions are as follows..
Page g of 35

t*cuSign ID D￿D39CF4lts￿1e￿￿e74o￿l9Al52626
Intemational Agency for the Prevention of Blindness.. cons01￿ated Report and Finan￿81 Ststement5 for the Year Ended 31 De(Ember 2023
Geopolitical event5, including wars, economic pressures, currency markets and health epidemics may undenrin8 IAPB'S r81evance and
ability to operate effectively.
Mitigating actions indude. ensuring our policy and 8dvocacy work remains relevant, ensuring effective communications with member
organisations, scrutiny of finanaal management based on s prudent approach and hO￿ing of cash balan￿S in dollars.
Failure to realise the ￿llectIVe advocacy power of the ￿PB network. Mitigating actions include. ongoing high profile engagement at the UN
and work wth governments and UN entities to tnobilise national action and cornmilments for vision. Develop and deliver global advocacy
strategy for the inclusion of the WHO global targets in UHC and the SDGS.. and support IAPB members lo advocate for greater ￿porting and
action on the targets.
Resou￿$ may become insuffic#ent lo deliver IAPB'S strategy and activity plan
Mitigating rneasures indude.. regular review of business and financial plans by the senior management team to inform workforce planning
and the allocation of resour￿$ a¢ross teams, a fows on staff engagement through new HR resources. staff surveys and an increased focus
on Stsff development,. increased investment in fundraising.. and p18nning required resources at the outset of new pmjects.
PLANS FOR FUTURE PERIODS
The charity plans an exciting and ambitlous programme for 2024 8nd beyond, including".
Advocacy. seeking change through high-level meetings to bring together govemments, donors and the private sector with our members wrth
the aim of turning commitment$ into tangible change for those most in need.
Carnpaign." building on our annual Love Your Eyes campaign, culminating in ourworfd Sight Day.
2030 Insight Live Mexico." our global event wll lake pla￿ In June 2024 for three days of transformative working.
Vision Atlas.. we wll release our improved data tool th8t shows the picture of eye health challenges around the world which will empower the
sectorto target resou[￿S effectively.
Exemplar wuntries.. wllaboration be￿en our members and governments in eight key countries to mobilise progress.
Sy5tern leadership." we plan to launch a leadership development initiative across all regions. Growth.. we are investing further in our
fundraising team wth the aim of a￿ssing new funding opportunrties lo fuel tt)e delivery of our ambitious plans.
Page 10 of 35

t*cuSign ID D￿D39CF4lts￿1e￿￿e74o￿l9Al52626
Intemational Agency for the Prevention of Blindness.. cons01￿ated Report and Finan￿81 Ststement5 for the Year Ended 31 De(Ember 2023
STATEMENT OF TRUSTEES, RESPONSIBILITIES
The Twstees Iwho are also directors of IAPB for the purposes of company lawl are responsible for preparing the Trustees, Report and the financial
statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting
Pra¢ticel.
Company law requires the Tru5tee5 to prepare financial statements for each financial yearwhich give a true and fairview of the state of affairs of
the charrtable wmpany and of the incoming ￿sOUrceS and application of resour￿$, including the income and expenditure. ol the d)aritable group
for that period. In preparing these financial statements. the Trustees are ￿qUired to..
Seled suitable accounting poliaes and then apply them consistently
Observe the methods and principles in the Charitie$ SORP
Makejudgments and accounting estimates that are reasonable and prudent
State whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and eyplained In the
financial statements.. and
Prepare the finan￿al statements on the going COn￿r￿ ba51s unless it is inappropriate to pie5urne that the Charitab￿ company will continue i
business.
The Trustees ale responsible for keeping propel accounting record5 that di5ck)5e wth iea50nable a￿u[aCY at any tirne the financial pO￿tIon of the
¢haritable company and enab￿ them to ensu￿ that the financial statements comply with the CompaniesAct 2006. They are also ￿sponSible for
safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other
STATEMENT AS TO THE DISCLOSURE OF INFORMATION TO THE AUDITORS
Each of the mernbers of the Board who were in Offi￿ on the date of approval of these financial staternents has confirmed, as far as they are each
aware.
That there is no relevant audit infomation of which the auditors 8re unaware., 8nd
Each of the members of the Board has confimied that they have each taken all steps that they ought to have taken as members of Board In
order lo make themselves aware of any relevant audit information and to estsblish that it has been communicated to the auditor.
Page11 of35

t*cuSign ID D￿D39CF4lts￿1e￿￿e74o￿l9Al52626
Intemational Agency for the Prevention of Blindness.. cons01￿ated Report and Finan￿81 Ststement5 for the Year Ended 31 December 2023
APPROVAL
The Twstees, Report. which incorporates the Directors, Report, was approved by the Board on the 241h of June 2024 and signed on its behalf by..
Muhammad Babar Qureshl
ice President
Page 12 of 35

## **Opinion** 

We have audited the financial statements of International Agency for the 

ed and Charity 

Balance Sheets, the Consolidated Statement of Cash Flow and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice). 

In our opinion the financial statements: 

expenditure, for the year then ended; 

have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and have been prepared in accordance with the requirements of the Companies Act 2006. 

## **Basis for opinion** 

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in 

independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the lieve that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. 

## **Conclusions relating to going concern** 

In auditing the financial statements, we have concluded that the trustee's use of the going concern basis of accounting in the preparation of the financial statements is appropriate. 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or r a period of at least twelve months from when the financial statements are authorised for issue. 

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report. 

## **Other information** 

The trustees are responsible for the other information contained within the annual report. The other information comprises the information included ements does not cover the 



other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. 

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. 

We have nothing to report in this regard. 

## **Opinions on other matters prescribed by the Companies Act 2006** 

In our opinion based on the work undertaken in the course of our audit 

ort prepared for the purposes of company law, for the financial year 

- for which the financial statements are prepared is consistent with the financial statements; and 

e with applicable legal requirements. 

## **Matters on which we are required to report by exception** 

In light of the knowledge and understanding of the group and charitable company and their environment obtained in the course of the audit, we have not identified 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006  requires us to report to you if, in our opinion: 

adequate and proper accounting records have not been kept; or 

the financial statements are not in agreement with the accounting records and returns; or 

certain disclosures of trustees' remuneration specified by law are not made; or 

- we have not received all the information and explanations we require for our audit; or 

the trustees were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the 

## **Responsibilities of trustees** 

le company for the 

purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. 

e as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to 



liquidate the charitable company or to cease operations, or have no realistic alternative but to do so. 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether surance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. 

Details of the extent to which the audit was considered capable of detecting irregularities, including fraud and non-compliance with laws and regulations are set out below. 

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting www.frc.org.uk/auditorsresponsibilities 

## **Extent to which the audit was considered capable of detecting irregularities, including fraud** 

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We identified and assessed the risks of material misstatement of the financial statements from irregularities, whether due to fraud or error, and discussed these between our audit team members. We then designed and performed audit procedures responsive to those risks, including obtaining audit evidence sufficient and appropriate to provide a basis for our opinion. 

We obtained an understanding of the legal and regulatory frameworks within which the charitable company and group operates, focusing on those laws and regulations that have a direct effect on the determination of material amounts and disclosures in the financial statements. The laws and regulations we considered in this context were the Companies Act 2006 together with the Charities SORP (FRS102) 2019. We assessed the required compliance with these laws and regulations as part of our audit procedures on the related financial statement items. 

In addition, we considered provisions of other laws and regulations that do not have a direct effect on the financial statements but compliance with also considered the opportunities and incentives that may exist within the charitable company and the group for fraud. The laws and regulations we considered in this context for the UK operations were the Companies Act 2006, the Charities Act 2011, together with the Charities SORP (FRS 102). 

Auditing standards limit the required audit procedures to identify non-compliance with these laws and regulations to enquiry of the Trustees and other management and inspection of regulatory and legal correspondence, if any. 

We identified the greatest risk of material impact on the financial statements from irregularities, including fraud, to be within the recognition of grant, coalition and sponsorship income and the override of controls by management. Our audit procedures to respond to these risks included enquiries of management and the Audit Committee about their own identification and assessment of the risks of irregularities, sample testing on the posting of journals, designing audit procedures over grant, coalition and sponsorship income, reviewing accounting estimates for biases, reviewing regulatory correspondence with the Charity Commission and reading minutes of meetings of those charged with governance. 

Owing to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the 



financial statements, even though we have properly planned and performed our audit in accordance with auditing standards. For example, the further removed non-compliance with laws and regulations (irregularities) is from the events and transactions reflected in the financial statements, the less likely the inherently limited procedures required by auditing standards would identify it. In addition, as with any audit, there remained a higher risk of non-detection of irregularities, as these may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal controls. We are not responsible for preventing non-compliance and cannot be expected to detect non-compliance with all laws and regulations. 

## **Use of our report** 

T 

anies Act 2006. required to state to them in ty to anyone other than audit work, for this report, or for the opinions we have formed. 


**Kerry Brown Senior Statutory Auditor** For and on behalf of 

Crowe U.K. LLP, Statutory Auditor, Black Country House, Rounds Green Road, Oldbury, West Midlands, B69 2DG **Date: 09 September 2024** 




|Note<br>**COME FROM:**<br>haritable activities<br>Membership<br>Grants<br>2<br>Other income<br>3<br>vestment income<br>**otal income**<br>**XPENDITURE ON:**<br>aising funds<br>Income development<br>haritable activities<br>Global advocacy<br>Campaigns and<br>communications<br>Events<br>Knowledge<br>Strengthening the network<br>Coalition for clear vision<br>**otal expenditure**<br>4<br>**ET (EXPENDITURE)/INCOME**<br>**nd net movement in funds for**<br>**e year**<br>unds brought forward<br>**OTAL FUNDS CARRIED**<br>**ORWARD**<br>12|2023<br>2023<br>**2023**<br>2022<br>2022<br>2022<br>Unrestricted £<br>Restricted £<br>**Total £**<br>Unrestricted £<br>Restricted £<br>Total £<br>1,570,978<br>-<br>**1,570,978**<br>1,415,239<br>-<br>1,415,239<br>170,015<br>818,592<br>**988,607**<br>294,878<br>311,265<br>606,143<br>345,616<br>170,369<br>**515,985**<br>585,718<br>370,118<br>955,836<br>3,416<br>-<br>**3,416**<br>3,979<br>-<br>3,979|
|---|---|
||**2,090,025**<br>**988,961**<br>**3,078,986**<br>2,299,814<br>681,383<br>2,981,197|
||393,258<br>-<br>**393,258**<br>197,460<br>-<br>197,460<br>350,038<br>271,272<br>**621,310**<br>203,673<br>350,084<br>553,757<br>667,833<br>110,000<br>**777,833**<br>626,524<br>-<br>626,524<br>257,872<br>-<br>**257,872**<br>253,867<br>-<br>253,867<br>154,403<br>156,876<br>**311,279**<br>268,865<br>-<br>268,865<br>444,020<br>214,623<br>**658,643**<br>779,958<br>-<br>779,958<br>-<br>399,291<br>**399,291**<br>-<br>271,946<br>271,946|
||**2,267,424**<br>**1,152,062**<br>**3,419,486**<br>2,330,347<br>622,030<br>2,952,377|
||**(177,399)**<br>**(163,101)**<br>**(340,500)**<br>(30,533)<br>59,353<br>28,820<br>782,007<br>177,070<br>**959,077**<br>812,540<br>117,717<br>930,257|
||**604,608**<br>**13,969**<br>**618,577**<br>782,007<br>177,070<br>959,077|






|Note<br>**IXED ASSETS**<br>angible assets<br>8<br>nvestment in subsidiary<br>13<br>**otal fixed assets**<br>**URRENT ASSETS**<br>ebtors<br>9<br>ash at bank and in hand<br>**otal current assets**<br>**URRENT LIABILITIES**<br>reditors: amounts falling due within one year<br>10<br>**et current assets**<br>**et assets**<br>**unds**<br>estricted funds<br>nrestricted funds<br>**otal funds**<br>12|**Consolidated**<br>**Charity**<br>Consolidated<br>Charity<br>**2023**<br>**2023**<br>2022<br>2022<br>**£**<br>**£**<br>£<br>£<br>10,929<br>10,929<br>14,440<br>14,440<br>-<br>1<br>-<br>1|
|---|---|
||**10,929**<br>**10,930**<br>14,440<br>14,441|
||257,549<br>290,996<br>521,689<br>672,260<br>1,127,654<br>1,094,208<br>1,041,049<br>891,592|
||**1,385,203**<br>**1,385,204**<br>1,562,738<br>1,563,852<br>777,555<br>777,557<br>618,101<br>619,216|
||**607,648**<br>**607,647**<br>944,637<br>944,636|
|||
||**618,577**<br>**618,577**<br>959,077<br>959,077<br>13,969<br>13,969<br>177,070<br>177,070<br>604,608<br>604,608<br>782,007<br>782,007|
||**618,577**<br>**618,577**<br>959,077<br>959,077|







|**et income/ (expenditure) for the reporting period**<br>djustments for:<br>Depreciation charges<br>Loss on disposal of fixed assets<br>Decrease/ (increase) in debtors<br>(Decrease)/ increase in creditors<br>Net cash generated from/ used in) operating activities<br>**ash flows from investing activities**<br>Fixed asset additions<br>**nalysis of cash and cash equivalents**<br>ash at bank and in hand<br>**otal cash and cash equivalents**|**2023**<br>2022<br>**£**<br>£<br>**(340,500)**<br>28,820<br>11,342<br>10,569<br>-<br>1,603<br>264,140<br>(432,787)<br>159,454<br>(153,838)<br>94,436<br>(545,633)<br>(7,831)<br>(10,163)<br>**86,605**<br>**(555,796)**<br>**At 1 January**<br>**2023**<br>**Cash flow**<br>**At 31 December**<br>**2023**<br>**£**<br>**£**<br>**£**<br>1,041,049<br>86,605<br>1,127,654|
|---|---|
||**1,041,049**<br>**86,605**<br>**1,127,654**|





t*cuSign ID D￿D39CF4lts￿1e￿￿e74o￿l9Al52626
Intemational Agency for the Prevention of Blindness.. cons01￿ated Report and Finan￿81 Ststement5 for the Year Ended 31 De(Ember 2023
1. Basi5 of preparation. the finsncisl statements have been prep8ied under the historical cost convention and in accordan￿ with Financial
Reporting Standards applicable in the UK IFRS 1021 and the Companies Act 2006. They follow the recommendations in the Charities SORP120191,'
ststement of ReNmmended Practi￿ applicable to ¢haritie$ p￿par1rng their accounts in accordan￿ wth FRS 102 effective 1 January 2019.
2. The organisation Is a charitable company limited by guarantee, incorporated In England wa￿$. Its ￿giSte￿d Offi￿ and printspal plats of
business is. IAPB. The Northern Shell Building 4th Floor, 10 Lower Thames Street. London. EC3R 6AF. The ¢h8ritable comp8ny is exempt from
corporation tsx as all its income is charitsble and is applied for charitsble purpose5. IAPB meets the definition of a public benefit entity as defined
under FRS 102.
3. Going concern basis." as outlined in the Fin8ncisI Review the trustees have reasonable expectation that the ch8rity has the resources to
continue its activities for the foreseeable future. Accordingly they continue to adopt the going ￿n￿rrn basis In preparing the financial statements.
4. Group accounts have been prepared for the Intemational Agency for the Prevention of Blindness IIAPBI and rts wholly owned subsidiary
company, IAPB Trading Limited. The chaiity has taken advantage of the exemptions In FRS 102 frorn the requiretnentS to pie5ent a charity only
Cash Flow Statement and ￿rtain di$¢lo$Jre$ about the charity's finan¢ial instruments The charity has also taken advantage of the exemption
allowed under section 408 of the CompsniesAct 2006 and has not presented its own Statement of Financial Activities in these financial staternents.
The accounts have been consolidated on a line by line basis to include the resutts of IAPB Trading Limited. The results of IAPB Trading Limited are
shown separately in note 13.
5. Voluntary income Is re￿1Ve￿ by way of donations and gifts and Is induded In fvll in the statement of finantsal activities when [etsiVab￿.
Volunteer time is not included in the finan¢ial Statements.
6. Income recognition- Grants are recognised in full In the stalernent of financial activities in the year In which they are ￿e￿1vable. unless they
relate to a speufic future pen￿. in ¥vhich ¢a$e they are deferred. Membershlp fees are ￿￿nised in the financial statements in line with the
period in which Member5 are entitled to benefit5. Membership fees received in advall(￿ are deferred.
7. Glfts In klnd represent servi￿$ provided to the charity at no Cha￿e or goods donated for distribution or use by the charity. Goods or servi￿$
given for use by the charity are recognised when rel￿1Vable. Gifts in kind are valued st WSt if known or els8 the price th8 charity would othenNiS8
have paid for the assets or Servi￿S.
8. Support and governance costs are allocated across tharitable activities on the b85is of head count.
9. Resources expended are recognlsed In the period in they are incurred. Resour￿$ expended in pounds steding indude attrit>utable VAT
which rAnnot be recovered.
Page 20 of 35

t*cuSign ID D￿D39CF4lts￿1e￿￿e74o￿l9Al52626
Intemational Agency for the Prevention of Blindness.. cons01￿ated Report and Finan￿81 Ststement5 for the Year Ended 31 De(Ember 2023
10. Grants payable are charged lo the SOFA in accordance with the terms and conditions attached to the individual grant agreernents. Such grants
are recognised as expendilurt when the ¢onditions £tta¢hed are fulfilled- generally as money is requested by the grant recipient. Grants offered
Subject to condition$ whi¢h have not been met 8t the year*nd are noted as a commitment. but not as ac¢rued as expenditure.
12. Pen5ion$.' IAPB provides an 'auto*nrolment' pension scheme for UK staff. The pension cost charge shown under staff expenLl1tu￿ reprtsenls
contributions paid and payab￿ in the year. The assets of these s¢hemes are independent from IAPB and IAPB has no additional liability other than
for the payment of those contributions. Pension contributions are also rnade for international staff.
13. Temilnatlon beneflts proscribed by the employment Contract are accwed ¥vhen these are earned Iby virtue of length of Servi￿). Termination
P8ymentS 8re valued at the higher of the amount required bylaw or the amount proscxibed by the employment wntr8Ct and re￿nIsed when due
less the value of temination benefits previously accrued.
14. Depreclatlon 15 provided 8t rates r2lculated to write down the cost of each asset to rts estimated residual value over its expected useful life.
The depre￿atIOn rates in use are as follow5.
. Computer equipment Itangiblel 33D/o per annum
Items of equipment are capitalised where the purchase priTr exTreds £1,000. Depreciatlon Costs are allocated lo activrties on the basis of the use
of the related asset$ in those a¢tivitie$. Expenditure on the development of web resources Ilntangible a$setsl are expensed in the year. Prior to
2020 the cost5 associated with IntangibleA5set5 once fully operational, were amortised overtheir useful life.
15.Ca$h at bank and In hand in¢ludes money held in current acwunt$ and any fund$ in n& noti￿ deposits and money market deposrts.
16. Debtors are valued at the amounts owing ltsr prepaidl less a provision for doubttul debt. Amounts in foreign Cur￿n￿e$ a￿ valued at the rates of
exthange ruling at the balan￿ sheet date.
17. Financial in5trum8nts are initially recognised at the amount receivable or payable induding any related transaction cost5. They are he￿ at
amortised Cost,. that is the amount Initially recognised less any principal repaid plus any interest a¢crued. Financial assets held a￿ cash and bank
and in hand. together with trade and other debtors. Financial liabilities are trade and other creditors.
18.¢reditors are valued at the amounts owing lor Income re￿Ived in advance). Amounts In fo￿l9n Cur￿ noes a￿ valued at the rates of exchange
ruling at the balance sheet date.
19.Restrlcted funds are to be used for specific purposes as laid down by the donor. EXpendrtU￿ which meets these crrteria is charged to the fund,
this may indude a fair allocation of management and support costs where allowed by the donor.
Page 21 of 35

t*cuSign ID D￿D39CF4lts￿1e￿￿e74o￿l9Al52626
Intemational Agency for the Prevention of Blindness.. cons01￿ated Report and Finan￿81 Ststement5 for the Year Ended 31 De(Ember 2023
20. Unrestricted funds are donations and other incoming reSOur￿S ￿￿1Vable or generated for the objects of the charity. Income 15 rel￿gNised
when there Is eviden¢e ol entitlement, the arnounl can be measured and the ￿CeIpt Is probable. whe￿ terms and conditions have not been met. or,
unctrtainly exists as to whether IAPB can meet the terms and ¢ondition$ othenMi$e within its control, the income is not rewgnised but deferred a$ a
liability until it is probable that the terms and conditions imposed be met.
21. Forelgn exchange gains and losse8 are recorded in the Statement of Finan¢ial Activities as a nel cost of the relevant a¢tivity. Transa¢tsons in
foreign currencies are translated into pounds sterling at a daily rate based on mid-market opening rate at midnight.
22. The￿ are no Sources of estlmatlon uncertalnty that have a significant effect on the amounts ￿￿nised in the financial statements.
Page 22 of 35


|CBM Christoffel-Blindenmission<br>Chen Yet Sen Family Foundation<br>CooperVision<br>Essilor<br>F Hoffmann-La Roche<br>Fred Hollows Foundation<br>Himalayan Cataract Project<br>slamic Solidarity Fund for Development<br>Lions Club International Foundation<br>National Vision<br>NVS Kenya Limited<br>Onesight<br>Restoring Vision<br>SEVA<br>Sightsavers<br>Singapore Tourist Board<br>The Vision Council<br>Vision Spring<br>World Diabetes Foundation<br>World Health Organisation (WHO)<br>Yonsei University<br>Other grants and donations (£5,000 or less)|**2023**<br>**2023**<br>**2023**<br>2022<br>2022<br>2022<br>**Unrestricted**<br>**Restricted**<br>**Total**<br>Unrestricted<br>Restricted<br>Total<br>**£**<br>**£**<br>**£**<br>£<br>£<br>£<br>-<br>67,451<br>67,451<br>-<br>112,700<br>112,700<br>150,000<br>150,000<br>300,000<br>274,000<br>-<br>274,000<br>24,235<br>24,235<br>-<br>-<br>-<br>-<br>11,253<br>11,253<br>-<br>-<br>-<br>-<br>42,500<br>42,500<br>-<br>75,000<br>75,000<br>-<br>52,123<br>52,123<br>-<br>45,022<br>45,022<br>-<br>11,629<br>11,629<br>-<br>-<br>-<br>-<br>71,419<br>71,419<br>-<br>-<br>-<br>-<br>30,439<br>30,439<br>-<br>-<br>-<br>-<br>26,366<br>26,366<br>-<br>-<br>-<br>-<br>87,276<br>87,276<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>9,685<br>9,685<br>-<br>11,629<br>11,629<br>-<br>-<br>-<br>-<br>79,130<br>79,130<br>-<br>39,803<br>39,803<br>-<br>61,500<br>61,500<br>-<br>9,685<br>9,685<br>-<br>10,000<br>10,000<br>-<br>-<br>-<br>-<br>39,385<br>39,385<br>-<br>9,685<br>9,685<br>-<br>11,629<br>11,629<br>-<br>9,685<br>9,685<br>-<br>20,468<br>20,468<br>8,387<br>-<br>8,387<br>20,015<br>-<br>20,015<br>-<br>-<br>-<br>-<br>5,883<br>5,883<br>-<br>-<br>-<br>-<br>4,277<br>4,277<br>12,491<br>-<br>12,491<br>**170,015**<br>**818,592**<br>**988,607**<br>294,878<br>311,265<br>606,143|
|---|---|





|ommercial Income and Sponsorship<br>oalition for Clear Vision project<br>ther Income|**2023**<br>**2023**<br>**2023**<br>2022<br>2022<br>2022<br>**Unrestricted**<br>**Restricted**<br>**Total**<br>Unrestricted<br>Restricted<br>Total<br>**£**<br>**£**<br>**£**<br>£<br>£<br>£<br>330,456<br>-<br>**330,456**<br>554,736<br>-<br>554,736<br>-<br>170,369<br>**170,369**<br>-<br>370,118<br>370,118<br>15,160<br>-<br>**15,160**<br>30,982<br>-<br>30,982<br>**345,616**<br>**170,369**<br>**515,985**<br>585,718<br>370,118<br>955,836|
|---|---|



|taff costs<br>ravel and meetings<br>vents and conferences<br>onsultancy and other activity costs<br>nline resources and promotions<br>ther costs<br>xchange losses/ (gains)<br>upport and governance costs<br>**otal**<br>_022_|**Global**<br>**Advocacy**<br>**Campaigns and**<br>**Communications**<br>**Events**<br>**Knowledge**<br>**Strengthening**<br>**the Network**<br>**Coalition**<br>**for Clear**<br>**Vision**<br>**Support and**<br>**Governance**<br>**Total 2023**<br>_Total 2022_<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>_£_<br>328,961<br>296,280<br>-<br>84,733<br>494,410<br>-<br>164,105<br>1,368,489<br>_1,323,643_<br>8,935<br>32,384<br>63,800<br>12,132<br>111,253<br>24,665<br>51,888<br>305,057<br>_418,258_<br>14,406<br>8,822<br>72,166<br>2,810<br>41,718<br>2,460<br>18,833<br>161,215<br>_119,364_<br>138,059<br>170,451<br>74,045<br>134,669<br>54,028<br>343,498<br>168,758<br>1,083,508<br>_799,704_<br>-<br>62,917<br>21,787<br>-<br>-<br>-<br>-<br>84,704<br>_27,867_<br>3,274<br>3,481<br>1,148<br>755<br>120,990<br>18,509<br>188,839<br>336,996<br>_384,064_<br>72<br>(667)<br>(595)<br>(382)<br>25,337<br>10,159<br>45,593<br>79,517<br>_(120,523)_<br>**493,707**<br>**573,668**<br>**232,351**<br>**234,717**<br>**847,736**<br>**399,291**<br>**638,016**<br>**3,419,486**<br>_2,952,377_<br>127,603<br>204,165<br>25,521<br>76,562<br>204,165<br>-<br>(638,016)<br>-<br>**621,310**<br>**777,833**<br>**257,872**<br>**311,279**<br>**1,051,901**<br>**399,291**<br>**-**<br>**3,419,486**<br>_553,757_<br>_626,524_<br>_253,867_<br>_268,865_<br>_977,418_<br>_271,946_<br>_-_<br>_2,952,377_|
|---|---|






|**022**<br>taff costs<br>ravel and meetings<br>vents and conferences<br>onsultancy and other activity costs<br>nline resources and promotions<br>ther costs<br>xchange (gains)<br>upport and governance costs<br>otal|**Global**<br>**Advocacy**<br>**Campaigns and**<br>**Communications**<br>**Events**<br>**Knowledge**<br>**Strengthening**<br>**the Network**<br>**Coalition**<br>**for Clear**<br>**Vision**<br>**Support and**<br>**Governance**<br>**Total 2022**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>348,594<br>313,963<br>-<br>89,790<br>523,917<br>-<br>47,379<br>1,323,643<br>14,755<br>53,480<br>105,361<br>20,035<br>183,725<br>17,237<br>23,665<br>418,258<br>12,112<br>7,417<br>60,676<br>2,363<br>35,076<br>1,719<br>-<br>119,364<br>135,530<br>167,329<br>72,689<br>132,202<br>53,038<br>240,054<br>(1,138)<br>799,704<br>-<br>17,633<br>6,106<br>-<br>-<br>-<br>4,128<br>27,867<br>3,204<br>3,405<br>1,123<br>739<br>118,363<br>12,936<br>244,294<br>384,064<br>-<br>-<br>-<br>-<br>-<br>-<br>(120,523)<br>(120,523)|
|---|---|
||514,196<br>563,227<br>245,955<br>245,128<br>914,120<br>271,946<br>197,805<br>2,952,377<br>39,561<br>63,298<br>7,912<br>23,737<br>63,298<br>-<br>(197,805)<br>-|
||553,757<br>626,524<br>253,867<br>268,865<br>977,418<br>271,946<br>-<br>2,952,377|



## **5. NET (EXPENDITURE) / INCOME** 

|Net (expenditure)/income is stated after charging the following:|**2023**||2022|
|---|---|---|---|
||**£**||£|
|Depreciation|11,342||10,569|
|Auditors' remuneration :||||
|Charity audit|18,885||12,045|
|Other services|2,950|-||







|**ff costs**<br>aries and wages<br>ial security costs<br>sion<br>er staff costs<br>mination benefits|**2023**<br>**£**<br>**1,166,249**<br>**59,245**<br>**101,335**<br>**41,659**<br>**-**<br>**1,368,488**|2022<br>£<br>1,102,183<br>72,633<br>100,481<br>36,346<br>12,000<br>**1,323,643**|
|---|---|---|



of employees whose emoluments for the year   within the following bands were: 



Owing to the diverse nature of the organisation and its international presence, IAPB uses the services of contractors and consultants to supplement its core staff. In this regard, there were a variety of legal engagements, depending on various factors such as location, role, need for flexibility etc. The figures shown above as salaries and wages reflect those staff employed directly by the IAPB in London and South Africa on IAPB contracts. Other personnel, to all intents and purposes part of the IAPB core team although not on a direct IAPB staff employment contract, are included as secondees, contractors, consultants. The average headcount figure includes the effective number of people involved in overall IAPB global operations. 

|perations.||
|---|---|
|**Average Head Count**<br>Global Advocacy<br>Strengthening the Network<br>Campaigns and Communications<br>Events<br>Support and Governance costs<br>**Total**|**2023**<br>**2022**<br>**5**<br>8<br>**8**<br>3<br>**11**<br>7<br>**1**<br>4<br>**2**<br>1|
||**27**<br>**23**|







|**Cost**<br>At 1 January 2023<br>Additions during the year<br>Disposal during the year<br>At 31 December 2023<br>**Depreciation**<br>At 1 January 2023<br>Charge for the year<br>Disposal during the year<br>At 31 December 2023<br>**Net book value**<br>**At 31 December 2023**<br>At 31 December 2022|Tangible<br>Intangible<br>**Total**<br>£<br>£<br>**£**<br>36,713<br>140,709<br>**177,422**<br>7,831<br>-<br>**7,831**<br>(2,827)<br>-<br>**(2,827)**|
|---|---|
||**41,717**<br>**140,709**<br>**182,426**|
||22,273<br>140,709<br>**162,982**<br>11,342<br>-<br>**11,342**<br>(2,827)<br>-<br>**(2,827)**|
||**30,788**<br>**140,709**<br>**171,497**|
|||
||**10,929**<br>**-**<br>**10,929**|
||14,440<br>-<br>14,440|





|**EBTORS**<br>e debtors<br>unts owing by subsidiary<br>ayments<br>er debtors<br>**CREDITORS**<br>e creditors<br>ruals<br>erred income<br>er creditors<br>ation and Social Security|**Group**<br>**Charity**<br>Group<br>Charit<br>**2023**<br>**2023**<br>2022<br>202<br>**£**<br>**£**<br>**£**<br><br>161,275<br>161,275<br>436,649<br>436,64<br>-<br>33,447<br>-<br>150,57<br>22,853<br>22,853<br>36,970<br>36,97<br>73,421<br>73,421<br>48,070<br>48,07|
|---|---|
||**257,549**<br>**290,996**<br>521,689<br>672,26|
||**Group**<br>**Charity**<br>Group<br>Charit<br>**2023**<br>**2023**<br>2022<br>2,02<br>**£**<br>**£**<br>£<br><br>84,963<br>84,963<br>124,986<br>124,98<br>109,028<br>109,028<br>42,526<br>42,52<br>538,472<br>538,472<br>416,257<br>416,25<br>36,652<br>36,654<br>-<br><br>8,440<br>8,440<br>34,332<br>35,44|
||**777,555**<br>**777,557**<br>618,101<br>619,21|



## **Deferred income movements in the year** 

|||Release|||
|---|---|---|---|---|
||At 31|from|Addition|**At 31**|
||December|previous|in current|**December**|
||2022|year|year|**2023**|
||**£**|**£**|£|**£**|
|Membership|127,398|127,398|318,108|**318,108**|
|Grants|248,607|248,607|167,000|**167,000**|
|Events|40,252|40,252|53,364|**53,364**|
|Total deferred income|416,257|416,257|538,472|**538,472**|





## **11. ANALYSIS OF GROUP NET ASSETS BETWEEN FUNDS** 

|**023**<br>angible fixed assets<br>et current assets<br>**roup net assets at the end of the year**<br>**022**<br>angible fixed assets<br>et current assets<br>roup net assets at the end of the year|**Restricted**<br>**funds**<br>**General**<br>**funds Total funds**<br>**£**<br>**£**<br>**£**<br>-<br>10,929<br>**10,929**<br>13,969<br>593,679<br>**607,648**|
|---|---|
||**13,969**<br>**604,608**<br>**618,577**|
||-<br>14,440<br>14,440<br>177,070<br>767,567<br>944,637|
||177,070<br>782,007<br>959,077|






|**12. MOVEMENT IN FUNDS**<br>**At the start**<br>**of the year**<br>**Incoming**<br>**resources**<br>**Outgoing**<br>**resources**<br>Transfers<br>between<br>funds<br>**At the end**<br>**of the year**<br>**£**<br>**£**<br>**£**<br>£<br>**£**<br>**RESTRICTED FUNDS**<br>**Global Advocacy**<br>a. Friends of Vision Secretariat - various funders<br>-<br>81,165<br>81,165<br>-<br>-<br>b. Retinopathy advocacy<br>- Coopervision<br>-<br>24,235<br>24,235<br>-<br>-<br>- National Vision<br>-<br>26,366<br>26,366<br>-<br>-<br>- The Vision Council<br>-<br>26,853<br>26,853<br>-<br>-<br>c. Advocacy to Action<br>- CBM Christoffel-Blindenmission<br>-<br>5,418<br>5,418<br>-<br>-<br>- F Hoffmann-La Roche<br>-<br>7,500<br>7,500<br>-<br>-<br>- Lions Club International Foundation<br>-<br>4,500<br>4,500<br>-<br>-<br>d. Capacity Development Programme<br>- Islamic Solidarity Fund for Development, IsDB<br>-<br>12,893<br>12,893<br>-<br>-<br>-<br>e. Global Advocacy and Policy Framework: Fred Hollows Foundation<br>-<br>30,465<br>30,465<br>-<br>-<br>f. World Report on Vision roll-out: CBM Christoffen-Blindenmission<br>-<br>31,409<br>31,409<br>-<br>-<br>g. Diabetic Retinopathy: World Diabetes Foundation<br>-<br>20,468<br>20,468<br>-<br>-<br>**Campaigns and Communications**<br>h.<br>- Chen Yet Sen Family Foundation<br>-<br>100,000<br>100,000<br>-<br>-<br>i.<br>- Singapore Tourism Board<br>-<br>10,000<br>10,000<br>-<br>-<br>**Knowledge**<br>j. Global Refractive Error Market Report<br>- Chen Yet Sen Family Foundation<br>-<br>50,000<br>50,000<br>-<br>-<br>- Sightsavers<br>-<br>50,000<br>50,000<br>-<br>-<br>k. Elevating Investment in Eye Health Report: F. Hoffmann-La Roche<br>-<br>35,000<br>35,000<br>-<br>-<br>l. Vision Atlas: CBM Christoffel-Blindenmission<br>-<br>11,778<br>11,778<br>-<br>-<br>m. School Eye Health Guidelines: Fred Hollows Foundation<br>-<br>10,098<br>10,098<br>-<br>-<br>**Strengthening the Network**<br>n. Sightfirst Research: Lions Club International Foundation<br>-<br>25,939<br>10,893<br>-<br>15,046<br>o. Capacity Development Programme<br>- Islamic Solidarity Fund for Development, IsDB<br>-<br>58,526<br>22,752<br>-<br>35,774<br>p. Systems Change Project for Latin America: SEVA<br>-<br>79,130<br>64,130<br>-<br>15,000<br>q. Advancing IPEC 2023 Regional Dissemination: Fred Hollows Foundation<br>-<br>11,560<br>11,560<br>-<br>-<br>r. Africa Partnership Funding:<br>- NVS Kenya Limited<br>-<br>87,276<br>87,276<br>-<br>-<br>- Swiss Red Cross (Schweizerisches Rotes Kreuz)<br>-<br>4,277<br>4,277<br>-<br>-<br>s. Insight Live Exemplar Development: CBM Christoffel-Blindenmission<br>-<br>7,852<br>7,852<br>-<br>-<br>t. Western Pacific Sponsorship: Yonsei University<br>-<br>5,883<br>5,883<br>-<br>-<br>-<br>u.**The Coalition for Clear Vision**<br>177,070<br>170,370<br>399,291<br>-<br>(51,851)<br>**TOTAL RESTRICTED FUNDS**<br>**177,070**<br>**988,961**<br>**1,152,062**<br>**-**<br>**13,969**<br>**UNRESTRICTED FUNDS**<br>**General funds**<br>**782,007**<br>**2,090,025**<br>**2,267,424**<br>**-**<br>**604,608**|**12. MOVEMENT IN FUNDS**<br>**At the start**<br>**of the year**<br>**Incoming**<br>**resources**<br>**Outgoing**<br>**resources**<br>Transfers<br>between<br>funds<br>**At the end**<br>**of the year**<br>**£**<br>**£**<br>**£**<br>£<br>**£**<br>**RESTRICTED FUNDS**<br>**Global Advocacy**<br>a. Friends of Vision Secretariat - various funders<br>-<br>81,165<br>81,165<br>-<br>-<br>b. Retinopathy advocacy<br>- Coopervision<br>-<br>24,235<br>24,235<br>-<br>-<br>- National Vision<br>-<br>26,366<br>26,366<br>-<br>-<br>- The Vision Council<br>-<br>26,853<br>26,853<br>-<br>-<br>c. Advocacy to Action<br>- CBM Christoffel-Blindenmission<br>-<br>5,418<br>5,418<br>-<br>-<br>- F Hoffmann-La Roche<br>-<br>7,500<br>7,500<br>-<br>-<br>- Lions Club International Foundation<br>-<br>4,500<br>4,500<br>-<br>-<br>d. Capacity Development Programme<br>- Islamic Solidarity Fund for Development, IsDB<br>-<br>12,893<br>12,893<br>-<br>-<br>-<br>e. Global Advocacy and Policy Framework: Fred Hollows Foundation<br>-<br>30,465<br>30,465<br>-<br>-<br>f. World Report on Vision roll-out: CBM Christoffen-Blindenmission<br>-<br>31,409<br>31,409<br>-<br>-<br>g. Diabetic Retinopathy: World Diabetes Foundation<br>-<br>20,468<br>20,468<br>-<br>-<br>**Campaigns and Communications**<br>h.<br>- Chen Yet Sen Family Foundation<br>-<br>100,000<br>100,000<br>-<br>-<br>i.<br>- Singapore Tourism Board<br>-<br>10,000<br>10,000<br>-<br>-<br>**Knowledge**<br>j. Global Refractive Error Market Report<br>- Chen Yet Sen Family Foundation<br>-<br>50,000<br>50,000<br>-<br>-<br>- Sightsavers<br>-<br>50,000<br>50,000<br>-<br>-<br>k. Elevating Investment in Eye Health Report: F. Hoffmann-La Roche<br>-<br>35,000<br>35,000<br>-<br>-<br>l. Vision Atlas: CBM Christoffel-Blindenmission<br>-<br>11,778<br>11,778<br>-<br>-<br>m. School Eye Health Guidelines: Fred Hollows Foundation<br>-<br>10,098<br>10,098<br>-<br>-<br>**Strengthening the Network**<br>n. Sightfirst Research: Lions Club International Foundation<br>-<br>25,939<br>10,893<br>-<br>15,046<br>o. Capacity Development Programme<br>- Islamic Solidarity Fund for Development, IsDB<br>-<br>58,526<br>22,752<br>-<br>35,774<br>p. Systems Change Project for Latin America: SEVA<br>-<br>79,130<br>64,130<br>-<br>15,000<br>q. Advancing IPEC 2023 Regional Dissemination: Fred Hollows Foundation<br>-<br>11,560<br>11,560<br>-<br>-<br>r. Africa Partnership Funding:<br>- NVS Kenya Limited<br>-<br>87,276<br>87,276<br>-<br>-<br>- Swiss Red Cross (Schweizerisches Rotes Kreuz)<br>-<br>4,277<br>4,277<br>-<br>-<br>s. Insight Live Exemplar Development: CBM Christoffel-Blindenmission<br>-<br>7,852<br>7,852<br>-<br>-<br>t. Western Pacific Sponsorship: Yonsei University<br>-<br>5,883<br>5,883<br>-<br>-<br>-<br>u.**The Coalition for Clear Vision**<br>177,070<br>170,370<br>399,291<br>-<br>(51,851)<br>**TOTAL RESTRICTED FUNDS**<br>**177,070**<br>**988,961**<br>**1,152,062**<br>**-**<br>**13,969**<br>**UNRESTRICTED FUNDS**<br>**General funds**<br>**782,007**<br>**2,090,025**<br>**2,267,424**<br>**-**<br>**604,608**|
|---|---|
||**177,070**<br>**988,961**<br>**1,152,062**<br>**-**<br>**13,969**|
|||
||**782,007**<br>**2,090,025**<br>**2,267,424**<br>**-**<br>**604,608**|
|||
|**TOTAL FUNDS**|**959,077**<br>**3,078,986**<br>**3,419,486**<br>**-**<br>**618,577**|






|RESTRICTED FUNDS<br>e, Global and Regional Advocacy<br>CBM<br>The Fred Hollows Foundation<br>a, Friends of Vision Secretariat<br>various funders<br>r, Vision for Africa<br>Swiss Red Cross (Schweitzerisches Rotes<br>Kreuz)<br>v, European Vision Health Advocacy<br>F. Hoffmann-La Roche<br>u. The Coalition for Clear Vision<br>w. Communicating and Connecting Knowledge<br>SEVA Foundation<br>TOTAL RESTRICTED FUNDS<br>UNRESTRICTED FUNDS<br>General funds<br>TOTAL FUNDS|**At the**<br>**start of**<br>**the year**<br>**Incoming**<br>**resources**<br>**Outgoing**<br>**resources**<br>**Transfers**<br>**between**<br>**funds**<br>**At the**<br>**end of**<br>**the year**<br>**£**<br>**£**<br>**£**<br>£<br>**£**<br>-<br>102,999<br>102,999<br>-<br>-<br>-<br>35,440<br>35,440<br>-<br>-<br>-<br>58,023<br>58,023<br>-<br>-<br>38,819<br>-<br>38,819<br>-<br>-<br>-<br>75,000<br>75,000<br>-<br>-<br>78,898<br>370,118<br>271,946<br>-<br>177,070<br>-<br>39,803<br>39,803<br>-<br>-|
|---|---|
||117,717<br>681,383<br>622,030<br>-<br>177,070<br>812,540<br>2,299,814<br>2,330,347<br>-<br>782,007|
||930,257<br>2,981,197<br>2,952,377<br>-<br>959,077|





t*cuSign ID D￿D39CF4lts￿la￿5e74o￿l9Al52626
International Agency for the Prevention of Blindness". Consolidated Report and Finantsal Stalements forthe Year Ended 31 De￿rnber 2023
12. MOVEMENT IN FUNDS Icontinuerl)..
The purposes of the funds listed above were as follows..
a. Friends of Vision Secretariat.. IAPB provides secretariat support to the group of ambassadors al the UN who are member wuntries of the UN
FrEnds of Vision. This work is partly sUPPOrted by grant fvnding.
b. Refractive ErrorAdvo¢acy- supporting our advocacy work Induding the promotion of global targets for relradive error.
AdvocAcy to Action -SUPPOrting the development of tools and resources for member organisations to use when advocating at a national level.
d. Capacity development programme- this grant supports global advocacy work ￿1th the United Nations and at the World Health Organisation.
e. Global Advocacy and Policy Frameworf< - funding to support our global and regional advocacy work.
f. Worfd Report on Vision roll-out.. funding to support the dissefflination and promotion of reSOur￿S for Integrated People-centred Eye Care
IIPECI.
g. Diabeti¢ Retinopathy- these funds contribute toward$ advo¢a¢y for Diabetic Retinopathy screening targets and treabrent
h. These fund5 (xntribute to resourcing for our Love Your Eyes ￿MpaIgn.
singapo￿ Tourism 8oard- funding to support the 2030 In Sight Live event in Singapore in summer 2023.
j. Glob81 refrdctive error market report- this wss a signific8nt study into the Supply side market for gl88se8.
k. Elevatsng investment in eye health report- thi5 report was included within the Vision Ada5 and promoted to IAPB rnembers.
l. Vision Atlas- funding to support the development phase of the new Vision Atlas.
m. School Eye Health Guideline5- development of resour(￿3 for use by member5.
n. Sight first-funding to support researth to assess vision Impairment and effective ￿fraCtiVe error coverage among school d)I￿ren In fimor
L'este
o. Capacity development programme- funding to build advocacy capacity in Francophil8African countries.
p. Systems change project for Latin America- delivery ol systems change training and systems leadership capacity building.
q. Advancing IPEC- implementation of Integrated People-centred Eye Care for the Westem Pacifi'c region.
r. Africa Partnership funding- capacity-building in sub-saharan Africa induding research into the training of ophthalrnologists In Africa.
s. In Sight Live exemplar development- a grant to support the delivery of a session about exemplar countrie$ al the 2030 ISL event in Singapo￿.
t. Western Pacific sponsorship- these funds conthbute to developing and sUPPOrting 8dvoc8cy plans for the Western Paufic region.
u. The Coalrtion for Clear Vision- delivery of a coalition model to deliver glasses In Kenya and India.
v. European Vision Health Advoca¢y- developing a European advoca¢y and policy netrNork and plan.
w. Cornmunicating and Connecting KnO￿edge- funds for the tnaintenance and support of the Vision Ada5.
Page 33 of 35


|**Income and Expenditure**<br>Turnover<br>Cost of sales<br>Other expenses / (income)<br>Deficit/(surplus)<br>Donation to parent charity<br>Deficit / (surplus) after donation<br>Reserves brought forward<br>**Reserves carried forward**|**2023**<br>**202**<br>**£**|
|---|---|
||-|
||-<br>8,768<br>(13,32|
||8,768<br>(13,32<br>-<br>13,32|
||8,768<br>-|
||**8,768**|







|**Trustees**<br>Muhammad Babar Qureshi (Director, Inclusive Eye Health Initiative)<br>Rainer Brockhaus (CEO)<br>Bruce Spivey (Trustee of CBM Advisory Board)<br>Jennifer Chen<br>Jennifer Gersbeck (Global Advocacy Executive Director)<br>Amanda Davis (Director of Strategic Initiatives)<br>Nick Kourgialis (Vice President)<br>Katherine Overbey (CEO)<br>Jess Blijkers (International Director, Programmes & Advocacy)<br>Wolfgang Gindorfer (Expert on Uncorrected Refractive Errors & Child Eye Health)<br>Dr Rohit Kanna, Network Director<br>Elizabeth Kurian, Trustee<br>Katherine Overbey (CEO)<br>Kashinath Bhoosnurmath (President and CEO)<br>Derek Hodkey (CEO)<br>Dr Suzanne Gilbert (Senior Director of Research and Strategic Opportunities)<br>Dr Caroline Harper (CEO)<br>Ella Gudwin|**Related organisations**<br>**CBM - Christoffel Blinden Mission,**<br>**Christian Blind Mission e.V.**<br>**Chen Yet-Sen Family Foundation**<br>**The Fred Hollows Foundation (FHF)**<br>Helen Keller International<br>**Himalayan Cataract Project**<br>**Light for the World**<br>**LVPEI Hyderabad Eye Institute**<br>Onesight<br>**Operation Eyesight Universal**<br>**Orbis International**<br>**Seva Foundation**<br>**Sightsavers**<br>**Vision Spring**|**2023**<br>**2023**<br>2022<br>2022<br>**Amount Received**<br>**Amount Paid**<br>Amount Received Amount Paid<br>**£**<br>**£**<br>£<br>£<br>89,905<br>27,927<br>140,993<br>-<br>300,000<br>-<br>-<br>-<br>62,123<br>180,472<br>125,930<br>-<br>-<br>-<br>4,328<br>-<br>11,629<br>-<br>-<br>-<br>75,565<br>-<br>4,190<br>-<br>-<br>90,189<br>-<br>106,000<br>-<br>-<br>60,400<br>-<br>-<br>109,566<br>9,753<br>-<br>8,372<br>-<br>4,328<br>-<br>104,565<br>-<br>193,959<br>-<br>100,300<br>-<br>77,254<br>-<br>58,872<br>-<br>-<br>-|
|---|---|---|




